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ABSTRACT 
The prevalence and trend of Hepatitis B Virus infection in 2966 patients attending clinics of Aminu 
Kano Teaching Hospital, Kano Nigeira was determined over a 3 year period 2001 to 2003. The samples 
was initially screened by latex agglutination techniques while the positive samples repeated by Enzyme 
linked Immunosorbent Assay (ELISA) technique for  confirmation. A seroprevalence of 23.3% units with 
coefficient variation of 22.5 to 24.1% were reported during the study period. More males (24.1%) than 
females 21.5% patients were observed to be seropositive for HBsAg. The differences was not however 
statistically significant. The overall trend in HBsAg seropositivity over the study period showed 21.7% in 
2001, 24.7% in 2002 and 22.4% in 2003 respectively. Despite the availability of methods by which these 
viruses can be detected and surveillance activities to reduce the occurrence of the infection, the virus 
continues to  constitute threat to health of the individuals. O u r  findings suggest that it is necessary to  
reappraise the need to intensify preventive measures in order to reduce the trend of HBV infections. 
Key Words: Hepatitis B, HbsAg, Blood, Serum, Samples 
INTRODUCTION 
Hepatitis B virus (HBV) is one of the 
most important hepatotropic viruses known to be 
transmitted sexually, percutaneously, by blood, 
blood products and is known to be endemic in 
Africa (18~2). Despite the availability of methods 
by which this virus can be detected and 
surveillance activities to reduce the occurrence of 
the infection, the virus continues to constitute a 
threat to the health of patients. Hepatitis B surface 
ami-gm (HBsAg) in the blood is the most useful 
marker of active HBV infection which appears in 
the blood exclusiwly a s  a component of the virus 
and as incomplete viral fams (3&4). 
It has been estimated that about one third of the 
world's population has been infected with HBV of 
which over 350 millions of them are said to chronic 
carriers (5). 
WHO estimates suggest that HBV results in two 
million deaths each year worldwide and 230,000 of 
these occuring in Afnca. Even though the 
incidence of acute hepatitis and death as a result of 
it is under reported, Nigeria appears to fall within 
the hyperendemic region of Sub-Saharan Africa. It 
has been reported that upto 25% of chronic carriers 
of HBV develop m.ous  liver diseases including 
chronic hepatitis, cirrhosis and hepatocellular 
carcinoma (5). 
Although the prevalence of HBsAg has 
been reported among blood donors in this centre 
(6), information on its prevalence and trend of 
infection among patients is not available. 
Therefore, the aim of this study is to present the 
carriage rate and the trend of HBV infection among 
patients in Aminu Kano Teaching Hospital, 
(AKTH) Kano. 
METHODS 
Serum samples were collected from 2%6 
consecutive patients presenting to Aminu Kano 
Teaching Hospital (AKTH) for a pend of three 
years from January 2001 to December 2003. They 
consist of 2095 males a d  871 fenralps Tbe age 
ranged from one year to 61 years. In 2001, 406 
specimens were collected while 1282 and 1278 
were collected in 2002 a d  3M-I wqedvely. The 
samples were screened f a  HBr4.g by latex 
agglutination technique. All positive samples were 
repeated using Enzyme Linked Immunosorbent 
Assay (ELISA) technique (pathogyme Omega 
Diagnostics, UK) for confirmation. 
/ 
RESULTS 
Out of the 2966 patients tested over the three year 
period, 691 (23.1%) were HBsAg positive. This 
gives a period prevalence of 23.3% with a 95% 
coefficient variation of 22.5% to 24.1%. Of the 
2095 male patients tested, 504 (24.1%) were 
HBsAg positive. Similarly, out of the 871 female 
subjects, 187 (21.5%) were positive. The 
differences was not statistically significant 
( ~ 0 . 1 3 ) .  An examination of the overall trend of 
HBsAg seropositivity over the three year study 
period showed 2 1.7% in 2001, 24.7% in 2002 and 
22.4% in 2003 respectively. The stratification of 
HBsAg seropositivity by age and by sex are shown 
in table I and I1 respectively. 
Table 111 Shows The T m d  d Aeprtitis B \?ms Surface Antigenemia Among Teaching Hospital Patients. 
Year Total Saeened Total Pos % 
Total 2,966 69 1 (23.1) 
X2 
x2(hlldF and at Pa,, = 13.81) .Highly significant 
Table 1 shows The Distribution of Hepatitis B surface Antigenemia according to Age -Groups. 
Age Group HBsAg HBsAg Total No.(%) 
(Years) Positive Negative 
No. (%) NO: (%) 
<I0 49(25.3) 145(74.7) 194( 1 00) 
Not stated 8(100.0) 8(lOO.O) 
Total 691(23.1) 2275(76.9) 2966(100) 
X* @ldF and at Poaol - (13.81) .Highly significant 
Table I1 shows The Gender Distribution of Hepatitis B surface Antigenemia among Teaching Hospital 
patients in Kano. 
Sex HBs Ag HBsAg Total 
Positive No. (%) Negative No.(%) 
Male 504(24.1) 1591(75.9) 2095(100.0) 
* ' .  
Female 187(12.5) 684(78.5) 871(100.0) ' 
Total 691(23.3) 2275(76.7) ., 2966(100.0) 
X' at l dF and P<0.05 = 2.3. Not significant , 
DISCUSSIOS persistent infection in chronic carriers and 
Viral Hepatitis is a major problem in progressively cause terminal liver diseases (3&7). 
Nigeria and constitute a threat to life of infected Studies have shown that the carrier rate of HBV in 
patients both h u n g  and old. HBV can cause Nigeria is between 8 - 22% with an estimated 
exposure rate of above 60% (8,96210). This is 
consistent with this study, which showed a 
prevalence rate of 23.1% over a 3-year period. This 
relatively stable rate may reflect the adequacy of 
blood transfusion services with respect to screening 
for HBV infection in blood donors (3). 
Although the seroprevalence rate 
observed in this study is consistent with other 
studies in Nigeria, it is however higher tlpn 10?4 
found in Pakistan (11&12) and 5% in India (13). 
But when compared with the rate obemd in h 
African countries, the seroprcvalemx rde d x x d  
in this study is lower than 79% repatcd in 
Ethiopia. 56.2% in Kenya ad 792% in 
Mozambique (5). A m c q  thc m i a m  viral 
Hepatitis, the HBV is rn dslnibmal and 
spreading at the tare m-hich is !n+ than HIV 
within the indiridm!s (131 Srmpmalcnrr talc of 
HBV has bxn reporred m palcms with diffcrcnt 
ailments in 51- & a S ~ k l c  Ccll discasc 
(14). Acute lcreric l-kwams ( I  5) .  Dlabctcs Mcllitus 
(16) and HepatoCdlolar Carr~noma (17). Thc 
prevalence in these \arias d- conditions arc 
not different from that h e d  In rhc m e  
population except for HcpatoCeltular C m m  
and Acute lcteric Hepatitis. 
There was no significant diffcrcncc in h c  
ptevalence rate of infection in the various age 
groups except for those in the age of above 
50ycars. This may be due to the small number of 
patients in this age group (Table 1). 
Converse1 y, the seropositivity in the males 
were higher than in The females patients (Table 1). 
This is also consistent with other authorsS who * 
reported a higher carriage rate of 77% in males 
than 50% in females in South Africa. The trend of 
infection within the study period is statistically 
significant (P<0.001). 
In Afnca. transmission of HBV is usually 
horizontal in childhood. The prevalence of HBV 
among pregnant women is said to be much lower 
than in Chinese women and so vertical 
transmission is less important. 
Some risk factors identified among the 
study subjects include previous blood transfusion, 
traditional surgery, scarification, occupational 
exposure and exposure to infccted sex partners. 
Social status appears to have no cffcct in carriage 
of HBV in this study population. 
I t  is ncccssary to reappraise mcasurcs of 
prevention of HBV infcction in order to reduce the 
trend of infection. Emphasis should be placed on 
immuniiration of thosc at risk, avoidance of sharp 
objccts and contaminatcd infcction, vigorous 
screening of all blood and blood products to be 
transfuxd, practicc of safcr scx. good personal 
hygicnc and hcalth workcrs must usc the Universal 
Prccaution for protcction. 
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